Casper Versus Precise Stent for the Treatment of Patients with Idiopathic Intracranial Hypertension.

Belachew, Nebiyat F.; Baschung, Severin; Almiri, William; Encinas, Ruben; Kaesmacher, Johannes; Dobrocky, Tomas; Schankin, Christoph J.; Abegg, Mathias; Piechowiak, Eike I.; Raabe, Andreas; Gralla, Jan; Mordasini, Pasquale (2021). Casper Versus Precise Stent for the Treatment of Patients with Idiopathic Intracranial Hypertension. (In Press). Clinical neuroradiology Springer-Verlag 10.1007/s00062-021-01024-2

[img]
Preview
Text
Belachew2021_Article_CasperVersusPrecise_Kaesmacher.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (743kB) | Preview

PURPOSE

We hypothesized that due to its specific characteristics, the CasperTM RX carotid stent (CP) might be particularly suitable for venous sinus stenting (VSS) in patients with idiopathic intracranial hypertension (IIH). To test this theory, we compared it to the commonly used Precise Pro RXTM stent (PP).

METHODS

A total of 15 patients with IIH (median age 28.7 years) were reviewed retrospectively. Technical aspects as well as periinterventional and postinterventional complication rates were examined in patients treated with CP (n = 10) and the PP (n = 5). Improvements in cerebrospinal fluid opening pressure (CSF OP), transstenotic pressure gradient (TSPG) and clinical symptoms were also assessed. Results are shown as percentages and respective P-values.

RESULTS

Stent delivery was easier and more successful with the CP than the PP (difficult/failed stent delivery 0.0% versus 57.1%). No severe peri- or postinterventional complications or instances of in-stent thrombosis and/or stenosis were observed during follow-up. Improvement of CSF OP and TSPG immediately after VSS as well as at 6‑month follow-up were comparable between the CP and PP groups. Both groups showed substantial and similar decreases in intensity and frequency of headache. Almost all patients with other IIH-related symptoms showed either improvement or complete resolution of the symptoms after VSS. All patients who were available for interview (n = 12/15) reported a substantial improvement in quality of life.

CONCLUSION

A VSS using the CP seems to be safe and effective. The CP may reduce the risk of difficult or failed stent delivery in patients with challenging intracranial venous anatomy.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology
04 Faculty of Medicine > Medical Education > Institute for Medical Education
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic and Interventional Neuroradiology
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurosurgery

UniBE Contributor:

Belachew, Nebiyat Filate; Baschung, Séverin; Almiri, William; Encinas, Rubén; Kaesmacher, Johannes; Dobrocky, Tomas; Schankin, Christoph Josef; Abegg, Mathias; Piechowiak, Eike Immo; Raabe, Andreas; Gralla, Jan and Mordasini, Pasquale

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1869-1447

Publisher:

Springer-Verlag

Language:

English

Submitter:

Maria de Fatima Henriques Bernardo

Date Deposited:

08 Jun 2021 09:34

Last Modified:

08 Jun 2021 09:34

Publisher DOI:

10.1007/s00062-021-01024-2

PubMed ID:

34003319

Uncontrolled Keywords:

Cerebrospinal fluid opening pressure Idiopathic intracranial hypertension Stent delivery Venous sinus stenosis Venous sinus stenting

BORIS DOI:

10.48350/156442

URI:

https://boris.unibe.ch/id/eprint/156442

Actions (login required)

Edit item Edit item
Provide Feedback